Akari Therapeutics (AKTX) Stock Chart & Stock Price History $1.13 -0.01 (-1.25%) Closing price 07/11/2025 03:53 PM EasternExtended Trading$1.14 +0.00 (+0.38%) As of 07/11/2025 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics Stock Price Performance The Akari Therapeutics (AKTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.69%, with a year-to-date return of -7.32%. In the past month, the stock has decreased 4.98%, reflecting recent market activity. As of the latest close, Akari Therapeutics traded at $1.13 with a market cap of $36.39 million and volume of 16,882 shares. Five years ago, the stock traded at a split-adjusted price of $39.60, representing a 97.14% decrease over that period. At the time, it had a market cap of $31.40 million and a volume of 7,650 shares. Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.96%1 Month Performance-4.98%3 Month Performance+5.67%Year-To-Date Performance-7.32%1 Year Performance-67.69%5 Year Performance-97.14% AKTX Stock Chart for Sunday, July, 13, 2025 AKTX Chart by TradingView Akari Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$1.15$1.13-1.25%$1.15$1.1116,882 shs$36.39 million07/10/2025$1.13$1.15+1.64%$1.15$1.126,065 shs$36.85 million07/09/2025$1.12$1.13+0.58%$1.14$1.1035,652 shs$36.25 million07/08/2025$1.11$1.12+0.90%$1.14$1.126,017 shs$36.04 million07/07/2025$1.18$1.11-5.93%$1.17$1.1114,407 shs$35.72 million07/04/2025$1.18$1.18$1.17$1.142,252 shs$37.97 million07/03/2025$1.16$1.18+2.16%$1.17$1.142,252 shs$37.97 million07/02/2025$1.17$1.16-0.86%$1.18$1.1035,570 shs$37.17 million07/01/2025$1.17$1.17-0.42%$1.18$1.166,993 shs$37.49 million06/30/2025$1.16$1.17+0.93%$1.18$1.168,121 shs$37.64 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$1.17$1.16-0.93%$1.20$1.1529,569 shs$37.30 million06/26/2025$1.16$1.17+0.86%$1.20$1.1622,819 shs$37.65 million06/25/2025$1.16$1.16$1.19$1.1513,018 shs$37.33 million06/24/2025$1.16$1.16$1.18$1.1531,311 shs$37.33 million06/23/2025$1.13$1.16+2.75%$1.21$1.1117,834 shs$37.33 million06/20/2025$1.15$1.13-1.83%$1.22$1.0928,281 shs$36.33 million06/19/2025$1.15$1.15$1.16$1.1245,916 shs$37.01 million06/18/2025$1.18$1.15-2.54%$1.16$1.1245,916 shs$37.01 million06/17/2025$1.09$1.18+8.26%$1.22$1.1132,955 shs$37.97 million06/16/2025$1.19$1.09-8.40%$1.25$1.0944,670 shs$35.07 million06/13/2025$1.17$1.19+1.64%$1.21$1.0845,410 shs$38.29 million06/12/2025$1.23$1.17-4.42%$1.26$1.1764,878 shs$37.67 million Related Companies Ventyx Biosciences Stock Chart Lexeo Therapeutics Stock Chart Theratechnologies Stock Chart Black Diamond Therapeutics Stock Chart ALT5 Sigma Stock Chart Lyell Immunopharma Stock Chart Inhibikase Therapeutics Stock Chart Skye Bioscience Stock Chart Galectin Therapeutics Stock Chart Greenwich LifeSciences Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKTX Stock Alerts